{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:19:07Z","timestamp":1791019147179,"version":"4.1.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ecl.2010.02.013","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T04:33:33Z","timestamp":1275712413000},"page":"419-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"title":["Vitamin D and Diabetes"],"prefix":"10.1016","volume":"39","author":[{"given":"Tatiana","family":"Takiishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conny","family":"Gysemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2010.02.013_bib1","series-title":"IDF diabetes atlas","year":"2009"},{"issue":"Suppl 6A","key":"10.1016\/j.ecl.2010.02.013_bib2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(02)01276-7","article-title":"Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities","volume":"113","author":"LeRoith","year":"2002","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2008.04.008","article-title":"Autoimmune mechanisms in type 1 diabetes","volume":"7","author":"Knip","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1463-1326.2007.00710.x","article-title":"Role of vitamin D in the pathogenesis of type 2 diabetes mellitus","volume":"10","author":"Palomer","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00125-007-0665-5","article-title":"Changing perspectives in diabetes: their impact on its classification","volume":"50","author":"Wilkin","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00592-009-0112-9","article-title":"Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities","volume":"46","author":"Resmini","year":"2009","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00125-005-1802-7","article-title":"Vitamin D and diabetes","volume":"48","author":"Mathieu","year":"2005","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02427278","article-title":"Pancreatic secretion in man with subclinical vitamin D deficiency","volume":"29","author":"Nyomba","year":"1986","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jn\/135.2.323","article-title":"Vitamin D in type 1 diabetes prevention","volume":"135","author":"Harris","year":"2005","journal-title":"J Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2010.02.013_bib11","first-page":"6","article-title":"Natural course of preclinical type 1 diabetes","volume":"57","author":"Knip","year":"2002","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/db08-1179","article-title":"Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR, DQ genotypes?","volume":"58","author":"Steck","year":"2009","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.ecl.2010.02.013_bib14","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N Engl J Med"},{"issue":"1\u20135","key":"10.1016\/j.ecl.2010.02.013_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2004.03.095","article-title":"CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans","volume":"89\u201390","author":"Lopez","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/eje.0.1460777","article-title":"Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus","volume":"146","author":"Pani","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib17","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db07-0652","article-title":"Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes","volume":"56","author":"Bailey","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib18","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/diabetes.51.7.2294","article-title":"Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians","volume":"51","author":"Ogunkolade","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/eji.200636043","article-title":"The vitamin D receptor gene FokI polymorphism: functional impact on the immune system","volume":"37","author":"van Etten","year":"2007","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.diabres.2006.10.018","article-title":"VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile","volume":"77","author":"Garcia","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.gene.6363875","article-title":"Genetics of type 1 diabetes mellitus","volume":"3","author":"Pociot","year":"2002","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diabetes.49.3.504","article-title":"Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans","volume":"49","author":"Pani","year":"2000","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2265.2000.00985.x","article-title":"Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population","volume":"52","author":"Chang","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/aje\/kwj278","article-title":"Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies","volume":"164","author":"Guo","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humimm.2008.01.008","article-title":"Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population","volume":"69","author":"Lemos","year":"2008","journal-title":"Hum Immunol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/eje.0.1490591","article-title":"Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population","volume":"149","author":"Turpeinen","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib27","doi-asserted-by":"crossref","first-page":"e8023","DOI":"10.1371\/journal.pone.0008023","article-title":"Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India","volume":"4","author":"Israni","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib28","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","article-title":"Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group","volume":"23","author":"Karvonen","year":"2000","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diab.37.8.1113","article-title":"Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group","volume":"37","year":"1988","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00592-009-0100-0","article-title":"The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland","volume":"47","author":"Sloka","year":"2010","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1289\/ehp.5941","article-title":"Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence","volume":"111","author":"Staples","year":"2003","journal-title":"Environ Health Perspect"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1177\/153537020422901108","article-title":"Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence","volume":"229","author":"Cantorna","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-008-1061-5","article-title":"The association between ultraviolet B\u00a0irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide","volume":"51","author":"Mohr","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2337\/diacare.21.7.1101","article-title":"Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia","volume":"21","author":"Karvonen","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diacare.20.4.530","article-title":"Incidence of IDDM in German children aged 0-14 years. A 6-year population-based study (1987\u20131993)","volume":"20","author":"Neu","year":"1997","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib36","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/dc09-0891","article-title":"Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth Study","volume":"32","author":"Kahn","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib37","first-page":"371","volume":"57","author":"Bouillon","year":"1995","journal-title":"Verh K Acad Geneeskd Belg"},{"issue":"4616","key":"10.1016\/j.ecl.2010.02.013_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.6310748","article-title":"1,25-dihydroxyvitamin D3 receptors in human leukocytes","volume":"221","author":"Provvedini","year":"1983","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/abbi.1999.1605","article-title":"Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system","volume":"374","author":"Veldman","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"44","key":"10.1016\/j.ecl.2010.02.013_bib40","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1073\/pnas.0506516102","article-title":"Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter","volume":"102","author":"Dong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jnr.20826","article-title":"1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12\/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis","volume":"83","author":"Muthian","year":"2006","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4049\/jimmunol.154.2.536","article-title":"Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells","volume":"154","author":"Guery","year":"1995","journal-title":"J Immunol"},{"issue":"4961","key":"10.1016\/j.ecl.2010.02.013_bib43","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.2113314","article-title":"A cell culture model for T lymphocyte clonal anergy","volume":"248","author":"Schwartz","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","article-title":"Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs","volume":"270","author":"Griffin","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib45","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/diabetes.51.7.2119","article-title":"Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3","volume":"51","author":"van Halteren","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2010.02.013_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1196\/annals.1337.030","article-title":"1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice","volume":"1037","author":"van Etten","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib47","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaut.2004.06.004","article-title":"1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis","volume":"23","author":"van Halteren","year":"2004","journal-title":"J Autoimmun"},{"issue":"14","key":"10.1016\/j.ecl.2010.02.013_bib49","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1002\/pmic.200800848","article-title":"Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D","volume":"9","author":"Ferreira","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.ecl.2010.02.013_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.2003.tb06057.x","article-title":"Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes","volume":"987","author":"Adorini","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib51","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T\u00a0cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.133.4.1748","article-title":"1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation","volume":"133","author":"Bhalla","year":"1984","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib53","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI111557","article-title":"Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)","volume":"74","author":"Rigby","year":"1984","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib54","first-page":"479","article-title":"Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3","volume":"59","author":"Nunn","year":"1986","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0024-3205(85)90630-7","article-title":"1,25-Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets","volume":"37","author":"Matsui","year":"1985","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib56","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI113004","article-title":"Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA","volume":"79","author":"Rigby","year":"1987","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ecl.2010.02.013_bib57","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin D3 has a direct effect on na\u00efve CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib58","first-page":"3739","article-title":"Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes","volume":"84","author":"Willheim","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib59","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/diabetes.51.5.1367","article-title":"1alpha,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice","volume":"51","author":"Gregori","year":"2002","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib60","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.0804064","article-title":"Expansion of antigen-specific regulatory T\u00a0cells with the topical vitamin D analog calcipotriol","volume":"182","author":"Ghoreishi","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1010015013211","article-title":"Vitamin D as a cytokine and hematopoetic factor","volume":"2","author":"Hewison","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mam.2008.05.004","article-title":"Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities","volume":"29","author":"Baeke","year":"2008","journal-title":"Mol Aspects Med"},{"issue":"9","key":"10.1016\/j.ecl.2010.02.013_bib63","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.4049\/jimmunol.0803217","article-title":"1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3","volume":"183","author":"Jeffery","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib64","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0192-0561(87)90043-9","article-title":"1 alpha,25-Dihydroxyvitamin D3 inhibits proliferative response of T- and B-lymphocytes in a serum-free culture","volume":"9","author":"Shiozawa","year":"1987","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2220\/biomedres.27.1","article-title":"Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity","volume":"27","author":"Imazeki","year":"2006","journal-title":"Biomed Res"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2010.02.013_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1900\/RDS.2005.2.182","article-title":"Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus","volume":"2","author":"Sia","year":"2005","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1079\/NRR2005104","article-title":"A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?","volume":"18","author":"Flores","year":"2005","journal-title":"Nutr Res Rev"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/er.2007-0015","article-title":"The role for endoplasmic reticulum stress in diabetes mellitus","volume":"29","author":"Eizirik","year":"2008","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib71","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0041-1345(97)00273-X","article-title":"1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro","volume":"29","author":"Hahn","year":"1997","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib72","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1210\/en.2002-220449","article-title":"1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20","volume":"143","author":"Riachy","year":"2002","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10495-006-3558-z","article-title":"1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor","volume":"11","author":"Riachy","year":"2006","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib74","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1210\/en.2004-1322","article-title":"1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice","volume":"146","author":"Gysemans","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib75","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","article-title":"Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3","volume":"37","author":"Mathieu","year":"1994","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib76","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/diab.41.11.1491","article-title":"1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice","volume":"41","author":"Mathieu","year":"1992","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2005.03.007","article-title":"1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells","volume":"24","author":"Decallonne","year":"2005","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2249.1998.00568.x","article-title":"1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes","volume":"112","author":"Casteels","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib79","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/endo.136.3.7867594","article-title":"Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060","volume":"136","author":"Mathieu","year":"1995","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib80","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00223-004-0118-9","article-title":"Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats","volume":"75","author":"Del Pino-Montes","year":"2004","journal-title":"Calcif Tissue Int"},{"issue":"25","key":"10.1016\/j.ecl.2010.02.013_bib81","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ecl.2010.02.013_bib82","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00007890-199805150-00014","article-title":"Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine","volume":"65","author":"Casteels","year":"1998","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib83","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1359\/jbmr.2001.16.11.2057","article-title":"In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice","volume":"16","author":"Mathieu","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib84","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2249.2002.01825.x","article-title":"Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3","volume":"128","author":"Gysemans","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib85","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","article-title":"Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor","volume":"17","author":"Zeitz","year":"2003","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db07-1095","article-title":"Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor","volume":"57","author":"Gysemans","year":"2008","journal-title":"Diabetes"},{"issue":"9292","key":"10.1016\/j.ecl.2010.02.013_bib87","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ecl.2010.02.013_bib88","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s001250051499","article-title":"Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring","volume":"43","author":"Stene","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib89","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ajcn\/78.6.1128","article-title":"Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study","volume":"78","author":"Stene","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s001250051112","article-title":"Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group","volume":"42","year":"1999","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib91","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2007.128579","article-title":"Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis","volume":"93","author":"Zipitis","year":"2008","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib92","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2337\/diacare.26.12.3237","article-title":"In utero dietary exposures and risk of islet autoimmunity in children","volume":"26","author":"Fronczak","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2010.02.013_bib93","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1196\/annals.1375.047","article-title":"Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk","volume":"1079","author":"Wicklow","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib94","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","article-title":"The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)","volume":"23","author":"Pitocco","year":"2006","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib95","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2337\/diacare.24.8.1460","article-title":"Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention","volume":"24","author":"Pozzilli","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmrr.977","article-title":"Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA)","volume":"25","author":"Li","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib97","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2008-1422","article-title":"Association between serum osteocalcin and markers of metabolic phenotype","volume":"94","author":"Pittas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2010.02.013_bib98","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S1262-3636(08)73394-9","article-title":"Abnormalities in insulin secretion in type 2 diabetes mellitus","volume":"34","author":"Guillausseau","year":"2008","journal-title":"Diabetes Metab"},{"issue":"6865","key":"10.1016\/j.ecl.2010.02.013_bib99","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: are we ignoring the evidence?","volume":"89","author":"Zittermann","year":"2003","journal-title":"Br J Nutr"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib101","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2337\/db08-0879","article-title":"Vitamin D and type 2 diabetes: are we ready for a prevention trial?","volume":"57","author":"Scragg","year":"2008","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib102","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","article-title":"Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey","volume":"27","author":"Scragg","year":"2004","journal-title":"Diabetes care"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib103","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","article-title":"Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction","volume":"79","author":"Chiu","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib104","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/diacare.28.5.1228","article-title":"Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","article-title":"Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990\u20132000","volume":"24","author":"Forouhi","year":"2007","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diab.30.5.382","article-title":"Effect of 1,25 dihydroxyvitamin D3 on insulin secretion","volume":"30","author":"Clark","year":"1981","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib107","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1079\/BJN19980055","article-title":"Inadequate vitamin D status: does it contribute to the disorders comprising syndrome \u2018X\u2019?","volume":"79","author":"Boucher","year":"1998","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib108","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/diacare.29.03.06.dc05-2148","article-title":"Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients","volume":"29","author":"Cigolini","year":"2006","journal-title":"Diabetes care"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2006.10.007","article-title":"Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory","volume":"77","author":"Giulietti","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2010.02.013_bib110","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib111","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1007\/s00125-009-1478-5","article-title":"Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle?","volume":"52","author":"Boucher","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib112","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00125-008-0993-0","article-title":"A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2\u00a0diabetes: studies in a new mouse model","volume":"51","author":"Oh","year":"2008","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib113","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/me.2004-0116","article-title":"The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro","volume":"18","author":"Huhtakangas","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2010.02.013_bib114","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.diabres.2005.03.003","article-title":"Genetics of type 2 diabetes mellitus","volume":"68","author":"Malecki","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1210\/edrv-10-3-294","article-title":"Vitamin D binding protein (Gc-globulin)","volume":"10","author":"Cooke","year":"1989","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib116","first-page":"1951","article-title":"Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance","volume":"85","author":"Hirai","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib117","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s001250050980","article-title":"Group specific component protein genotype is associated with NIDDM in Japan","volume":"41","author":"Hirai","year":"1998","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib118","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1530\/eje.0.1410490","article-title":"Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin","volume":"141","author":"Klupa","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8227(02)00020-7","article-title":"Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population","volume":"57","author":"Malecki","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib120","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3945\/ajcn.2008.26445","article-title":"Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women","volume":"89","author":"Sinotte","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"1\u20135","key":"10.1016\/j.ecl.2010.02.013_bib121","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jsbmb.2004.03.083","article-title":"Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states","volume":"89\u201390","author":"Uitterlinden","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib122","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2004.05.014","article-title":"Genetics and biology of vitamin D receptor polymorphisms","volume":"338","author":"Uitterlinden","year":"2004","journal-title":"Gene"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2010.02.013_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.02.016","article-title":"Vitamin D receptor polymorphisms and diseases","volume":"371","author":"Valdivielso","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib124","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/meta.2002.29969","article-title":"Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study","volume":"51","author":"Oh","year":"2002","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1464-5491.2003.00971.x","article-title":"The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men","volume":"20","author":"Ortlepp","year":"2003","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13685530802273426","article-title":"Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome","volume":"11","author":"Filus","year":"2008","journal-title":"Aging Male"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib127","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/eje.0.1450181","article-title":"Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset","volume":"145","author":"Ye","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2010.02.013_bib128","article-title":"Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population","author":"Dilmec","year":"2009","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0019-5359.53164","article-title":"Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study","volume":"63","author":"Bid","year":"2009","journal-title":"Indian J Med Sci"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2003-44711","article-title":"Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population","volume":"111","author":"Malecki","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib131","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0959-8049(01)00139-3","article-title":"Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers","volume":"37","author":"Speer","year":"2001","journal-title":"Eur J Cancer"},{"issue":"4458","key":"10.1016\/j.ecl.2010.02.013_bib132","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6250216","article-title":"Vitamin D deficiency inhibits pancreatic secretion of insulin","volume":"209","author":"Norman","year":"1980","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib133","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1210\/endo-113-4-1511","article-title":"Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion","volume":"113","author":"Chertow","year":"1983","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/endo-119-1-84","article-title":"Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo","volume":"119","author":"Cade","year":"1986","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib135","first-page":"426","article-title":"Renal diseases in diabetes mellitus","volume":"95","author":"Kumar","year":"1997","journal-title":"J Indian Med Assoc"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib136","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00252262","article-title":"Risk factors for worsening to diabetes in subjects with impaired glucose tolerance","volume":"26","author":"Kadowaki","year":"1984","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib137","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/diab.35.7.771","article-title":"Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats","volume":"35","author":"Chertow","year":"1986","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib138","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/endo-120-4-1490","article-title":"Rapid normalization\/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat","volume":"120","author":"Cade","year":"1987","journal-title":"Endocrinology"},{"issue":"18","key":"10.1016\/j.ecl.2010.02.013_bib139","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0024-3205(83)90685-9","article-title":"Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function","volume":"33","author":"Ishida","year":"1983","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0006-291X(89)91735-X","article-title":"The in vitro effect of 1 alpha,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets","volume":"164","author":"d'Emden","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/endo-127-1-39","article-title":"Evidence for involvement of protein kinase C and cyclic adenosine 3\u2032,5\u2032 monophosphate-dependent protein kinase in the 1,25-dihydroxy-vitamin D3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia)","volume":"127","author":"de Boland","year":"1990","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib142","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0701204","article-title":"Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat","volume":"121","author":"Bourlon","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib143","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1096\/fj.02-0225com","article-title":"Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice","volume":"16","author":"Hoenderop","year":"2002","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib144","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01269910","article-title":"The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro","volume":"3","author":"Milner","year":"1967","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2010.02.013_bib145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0083-6729(08)00616-X","article-title":"Insulin granule biogenesis, trafficking and exocytosis","volume":"80","author":"Hou","year":"2009","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib146","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2337\/diab.43.4.511","article-title":"What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism","volume":"43","author":"Rhodes","year":"1994","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib147","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2337\/diabetes.47.4.688","article-title":"Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians","volume":"47","author":"Hitman","year":"1998","journal-title":"Diabetes"},{"issue":"49","key":"10.1016\/j.ecl.2010.02.013_bib148","doi-asserted-by":"crossref","first-page":"15883","DOI":"10.1021\/bi962107y","article-title":"Ca2+ regulates calmodulin binding to IQ motifs in IRS-1","volume":"35","author":"Munshi","year":"1996","journal-title":"Biochemistry"},{"issue":"17","key":"10.1016\/j.ecl.2010.02.013_bib149","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1021\/bi992623z","article-title":"Binding of IRS proteins to calmodulin is enhanced in insulin resistance","volume":"39","author":"Li","year":"2000","journal-title":"Biochemistry"},{"issue":"5\u20136","key":"10.1016\/j.ecl.2010.02.013_bib150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0306-9877(03)00227-5","article-title":"PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight","volume":"61","author":"McCarty","year":"2003","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib151","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1210\/endo.134.4.8137721","article-title":"1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion","volume":"134","author":"Lee","year":"1994","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib152","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1210\/endo.139.4.5882","article-title":"Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen","volume":"139","author":"Huotari","year":"1998","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib153","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1210\/endo.136.7.7789310","article-title":"1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line","volume":"136","author":"Sergeev","year":"1995","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib154","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/endo.140.10.7025","article-title":"An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction","volume":"140","author":"Kajikawa","year":"1999","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.ecl.2010.02.013_bib155","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"Larsen","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib156","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.arcmed.2007.12.008","article-title":"Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats","volume":"39","author":"Chang-Quan","year":"2008","journal-title":"Arch Med Res"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib157","first-page":"155","article-title":"Effect of 1 alpha-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice","volume":"33","author":"Kawashima","year":"1981","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.ecl.2010.02.013_bib158","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fasebj.23.1_supplement.731.6","article-title":"Renal 25-hydroxycholecalciferol reabsorption is modulated in a type II diabetic rat model","volume":"23","author":"Anderson","year":"2009","journal-title":"FASEB J"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2010.02.013_bib159","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cccn.2005.02.020","article-title":"Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats","volume":"358","author":"de Souza Santos","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.ecl.2010.02.013_bib160","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1211\/jpp.59.12.0004","article-title":"Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats","volume":"59","author":"Ceylan-Isik","year":"2007","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib161","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1476-5381.1996.tb15546.x","article-title":"Effect of treatment with cholecalciferol on the membrane potential and contractility of aortae from spontaneously hypertensive rats","volume":"118","author":"Silva","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib162","first-page":"407","article-title":"Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women","volume":"8","author":"Nilas","year":"1984","journal-title":"Int J\u00a0Obes"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib163","first-page":"187","article-title":"Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus","volume":"1","author":"Inomata","year":"1986","journal-title":"Bone Miner"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib164","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02427083","article-title":"Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man","volume":"29","author":"Gedik","year":"1986","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.0954-6820.1987.tb10684.x","article-title":"Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance\u2014a prospective randomized double-blind study","volume":"222","author":"Ljunghall","year":"1987","journal-title":"Acta Med Scand"},{"issue":"824","key":"10.1016\/j.ecl.2010.02.013_bib166","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/pgmj.70.824.440","article-title":"Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D","volume":"70","author":"Kumar","year":"1994","journal-title":"Postgrad Med J"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib167","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","article-title":"Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians","volume":"38","author":"Boucher","year":"1995","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib168","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000188085","article-title":"Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3","volume":"68","author":"Allegra","year":"1994","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib169","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ajcn\/59.5.1083","article-title":"Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus","volume":"59","author":"Orwoll","year":"1994","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2362.1997.1520699.x","article-title":"No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects","volume":"27","author":"Fliser","year":"1997","journal-title":"Eur J Clin Invest"},{"issue":"872","key":"10.1016\/j.ecl.2010.02.013_bib171","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/pgmj.74.872.365","article-title":"Vitamin D replacement in Asians with diabetes may increase insulin resistance","volume":"74","author":"Taylor","year":"1998","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib172","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1742-1241.2003.tb10480.x","article-title":"The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients","volume":"57","author":"Borissova","year":"2003","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib173","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.29.03.06.dc05-1961","article-title":"Vitamin D and calcium intake in relation to type 2 diabetes in women","volume":"29","author":"Pittas","year":"2006","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib174","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/dc06-1994","article-title":"The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults","volume":"30","author":"Pittas","year":"2007","journal-title":"Diabetes care"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc07-1829","article-title":"Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative","volume":"31","author":"de Boer","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1464-5491.2008.02636.x","article-title":"A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men","volume":"26","author":"Nagpal","year":"2009","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib177","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2007-0298","article-title":"The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis","volume":"92","author":"Pittas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib178","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/EDE.0b013e318176b8ad","article-title":"Serum vitamin D and subsequent occurrence of type 2 diabetes","volume":"19","author":"Knekt","year":"2008","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib179","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0007114509992017","article-title":"Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial","volume":"103","author":"von Hurst","year":"2009","journal-title":"Br J Nutr"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ageing\/afp109","article-title":"Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438)","volume":"38","author":"Avenell","year":"2009","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib181","first-page":"161","article-title":"Insulin receptor gene mutations in Iranian patients with type II diabetes mellitus","volume":"13","author":"Kazemi","year":"2009","journal-title":"Iran Biomed J"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib182","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1017\/S0007114509297236","article-title":"Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study","volume":"102","author":"Holmes","year":"2009","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib183","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/dmrr.737","article-title":"Correlation between vitamin D3 deficiency and insulin resistance in pregnancy","volume":"24","author":"Maghbooli","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"10.1016\/j.ecl.2010.02.013_bib184","doi-asserted-by":"crossref","first-page":"e3753","DOI":"10.1371\/journal.pone.0003753","article-title":"Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus","volume":"3","author":"Zhang","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mehy.2009.07.054","article-title":"Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes","volume":"74","author":"Lapillonne","year":"2010","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib186","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s001250050640","article-title":"Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus","volume":"40","author":"Rudnicki","year":"1997","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib187","doi-asserted-by":"crossref","first-page":"F791","DOI":"10.1152\/ajprenal.00247.2009","article-title":"Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib188","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ki.5002002","article-title":"25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey","volume":"71","author":"Chonchol","year":"2007","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib189","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3122\/jabfm.2009.05.080231","article-title":"The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities","volume":"22","author":"Diaz","year":"2009","journal-title":"J Am Board Fam Med"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib190","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib191","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0009-9120(99)00085-5","article-title":"Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy","volume":"33","author":"Aksoy","year":"2000","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.ecl.2010.02.013_bib192","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archopht.125.5.661","article-title":"Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994","volume":"125","author":"Parekh","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib193","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/157016109788340686","article-title":"Vitamin D and cardiovascular disease","volume":"7","author":"Gouni-Berthold","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib194","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MAJ.0b013e3181aaee91","article-title":"Vitamin D deficiency and risk for cardiovascular disease","volume":"338","author":"Judd","year":"2009","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib195","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ajh.2009.105","article-title":"Vitamin D as potential baseline therapy for blood pressure control","volume":"22","author":"Bouillon","year":"2009","journal-title":"Am J Hypertens"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib196","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ajh.2009.88","article-title":"Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans","volume":"22","author":"Schmitz","year":"2009","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.ecl.2010.02.013_bib197","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1210\/jc.2008-0784","article-title":"Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography","volume":"93","author":"Pilz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ecl.2010.02.013_bib198","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1681\/ASN.2008111157","article-title":"25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification","volume":"20","author":"de Boer","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ecl.2010.02.013_bib199","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/en.2007-0805","article-title":"Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility","volume":"149","author":"Tishkoff","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib200","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jcb.21133","article-title":"VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells","volume":"100","author":"Wu-Wong","year":"2007","journal-title":"J Cell Biochem"},{"issue":"16","key":"10.1016\/j.ecl.2010.02.013_bib201","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/archinte.167.16.1730","article-title":"Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials","volume":"167","author":"Autier","year":"2007","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.ecl.2010.02.013_bib202","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.168.7.771","article-title":"Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain","volume":"168","author":"Lee","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/db08-0586","article-title":"Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.ecl.2010.02.013_bib204","first-page":"224","article-title":"Does type 2 diabetes predispose to osteoporotic bone fractures?","volume":"59","author":"Miazgowski","year":"2008","journal-title":"Endokrynol Pol"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2010.02.013_bib206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-291X(85)91679-1","article-title":"Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts","volume":"128","author":"Boland","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.ecl.2010.02.013_bib207","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archinternmed.2008.600","article-title":"Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials","volume":"169","author":"Bischoff-Ferrari","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ecl.2010.02.013_bib208","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2006-1404","article-title":"Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials","volume":"92","author":"Boonen","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852910000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852910000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:33:46Z","timestamp":1760175226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852910000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":208,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0889852910000150"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2010.02.013","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2010.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}